Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Reading disorder, Stress
Clinical narrative: Stroke, on the left side of his body; Difficulty walking; Difficulty moving his legs; Does not feel energetic; Difficulty reading after the stroke; Difficulty handling stress after the stroke; Felt sick; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke, on the left side of his body), GAIT DISTURBANCE (Difficulty walking), MUSCULAR WEAKNESS (Difficulty moving his legs), ASTHENIA (Does not feel energetic), READING DISORDER (Difficulty reading after the stroke) and STRESS (Difficulty handling stress after the stroke) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMINS [VITAMINS NOS], VITAMIN D NOS, VITAMIN B12 NOS, ALFUZOSIN HYDROCHLORIDE (UROXATRAL), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), FINASTERIDE, MAGNESIUM ASPARTATE, POTASSIUM ASPARTATE (POTASSIUM-MAGNESIUM-L-ASPARAGINATE), UBIDECARENONE (CO Q 10 [UBIDECARENONE]), APIXABAN (ELIQUIS), FLECAINIDE, VALSARTAN and ATORVASTATIN for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (Felt sick). On 03-Mar-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke, on the left side of his body) (seriousness criteria hospitalization, disability and medically significant). On an unknown date, the patient experienced GAIT DISTURBANCE (Difficulty walking) (seriousness criterion disability), MUSCULAR WEAKNESS (Difficulty moving his legs) (seriousness criterion disability), ASTHENIA (Does not feel energetic) (seriousness criterion disability), READING DISORDER (Difficulty reading after the stroke) (seriousness criterion disability) and STRESS (Difficulty handling stress after the stroke) (seriousness criterion disability). The patient was treated with Rehabilitation therapy for Cerebrovascular accident. On 14-Feb-2021, MALAISE (Felt sick) had resolved. At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke, on the left side of his body) outcome was unknown and GAIT DISTURBANCE (Difficulty walking), MUSCULAR WEAKNESS (Difficulty moving his legs), ASTHENIA (Does not feel energetic), READING DISORDER (Difficulty reading after the stroke) and STRESS (Difficulty handling stress after the stroke) had not resolved.            It was reported that the patient was in the hospital and had to go to rehabilitation after the stroke. The patient was having difficulty walking and moving his legs, difficulty reading, difficulty handling stress and he does not feel energetic following the stroke.  Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.